All Insights
Showing 1 - 12 of 2074
GDPR for HR
GDPR for HR Coffee Break | September 2026
Personal device disclosure obligations, managing DSAR requests, systemic compliance issues
Regulatory and compliance
EU clamps down on meat names for plant-based and cultivated alternatives
New rules for the use of meat terms will force plant-based and cultivated producers to rebrand ahead of a 2029
Advertising and marketing regulation
Marketinglaw: July and August 2026
Welcome to the latest edition of Marketinglaw
Tax
Box 3 and start-up to scale-up tax reforms put SARs in focus for Dutch employee incentives
The most extensive Dutch tax reforms in decades prompt founders and CEOs to rethink how to reward and retain their
The Building Safety Act
English TCC and FTT set out how to manage building safety claims across both jurisdictions
Landmark Wallace v Durkan ruling provides first guidance on how Building Safety Act claims will be managed and tried
The Building Safety Act
English High Court refuses reverse summary judgment on lawfulness of building safety remediation termination
Durkan v Wallace ruling makes clear that the Building Safety Act does not introduce a bespoke standard for repudiation
Life Sciences and Healthcare
English High Court grants dynamic website blocking order to tackle counterfeit medicines
Creative solution to IP and regulatory breaches gives life sciences companies greater control over unlawful online sales
The Building Safety Act
English court rules that building liability orders can apply to foreign companies
Technology and Construction Court opens the way for developers to recover remediation costs from overseas groups
Technology, Media and Telecommunications (TMT)
What is new on the French and EU audiovisual landscape?
Regulatory and legal developments for broadcasters, distributors and producers in the audiovisual industry
Regulatory and compliance
UK Immigration and Asylum Bill transforms modern slavery reporting by businesses
Bill proposes mandatory statement content, a new accuracy requirement and heavy financial penalties for non-compliance
Life Sciences and Healthcare
European courts and regulators target the intersection of regulatory and patent trends in the life sciences
The Tecfidera case and provisional pharma reform agreement put regulatory exclusivity and patent protection in focus
Life Sciences and Healthcare
EU pharma regulators publish annual AI observatory report
The EMA and HMA signal a shift from AI adoption to implementation, with coordinated AI pharma guidance underway
